By Eric Schweibenz
|
Jan
17
On January 17, 2018, the U.S. International Trade Commission (“Commission”) issued a press release announcing their vote to institute an investigation of Certain IoT Devices, Components Thereof (IOT, the Internet of Things) – Web Applications Displayed on a Web Browser (Inv. No. 337-TA-1094).  
 
By way of background, this investigation is based on an October 3, 2017 complaint filed by Dr. Lakshmi Arunachalam of Menlo Park, California alleging violation of Section 337 by way of unlawful importation into the U.S., selling for importation, and/or selling within the U.S. after importation certain Internet of Things (IoT) devices and components thereof (web application displayed on a web browser) that infringe U.S. Patent No. 7,930,340.  See our October 13, 2017 post for more details on the complaint.  The amended complaint further alleges unfair methods of competition and unfair acts (criminal and civil RICO violations, breach of contract, theft of intellectual property, antitrust violations, and trade secret misappropriation), the threat or effect of which is to destroy or substantially injure an industry in the United States.

Share

Read More

By Eric Schweibenz and Alex Englehart
|
Jan
11
On January 11, 2018, 10X Genomics, Inc. of Pleasanton, California (“10X Genomics”) filed a complaint (part 1, part 2, and part 3) requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that Bio-Rad Laboratories, Inc. of Hercules, California (“Bio-Rad”) unlawfully imports into the U.S., sells for importation, and/or sells within the U.S. after importation certain microfluidic systems, components thereof, and products containing the same that infringe one or more claims of U.S. Patent Nos. 9,644,204 (the ’204 patent), 9,689,024 (the ’024 patent), 9,695,468 (the ’468 patent), and 9,856,530 (the ’530 patent) (collectively, the “asserted patents”).
Share

Read More

By Eric Schweibenz
|
Jan
03
On January 3, 2018, the U.S. International Trade Commission (“Commission”) issued a press release announcing their vote to institute an investigation of Certain Mobile Electronic Devices and Radio Frequency and Processing Components Thereof (Inv. No. 337-TA-1093).

By way of background, this investigation is based on a November 30, 2017 complaint filed by Qualcomm Inc. of San Diego, California alleging violation of Section 337 by way of unlawful importation into the U.S., selling for importation, and/or selling within the U.S. after importation certain mobile electronic devices and radio frequency and processing components thereof that infringe one or more claims of U.S. Patent Nos. 9,154,356; 9,473,336; 8,063,674 ; 7,693,002; and 9,552,633. See our December 7, 2017 post for more details on the complaint.
Share

Read More

By Eric Schweibenz and Alex Englehart
|
Jan
02
On December 29, 2017, ZiiLabs Inc., Ltd. of Bermuda (“ZiiLabs”) filed a complaint (part 1 and part 2) requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that the following entities (collectively, the “Proposed Respondents”) unlawfully import into the U.S., sell for importation, and/or sell within the U.S. after importation certain graphics processors and products containing the same that infringe one or more claims of U.S. Patent Nos. 6,181,355 (the ’355 patent), 6,900,800 (the ’800 patent), 8,144,156 (the ’156 patent), and 8,643,659 (the ’659 patent) (collectively, the “asserted patents”):
Share

Read More

By Eric Schweibenz and Alex Englehart
|
Dec
29
On December 22, 2017, Neptune Subsea Acquisitions Ltd. of the United Kingdom, Neptune Subsea IP Ltd. of the United Kingdom, and Xtera, Inc. of Allen, Texas (“Xtera”) (collectively, “Complainants”) filed a complaint requesting that the ITC commence an investigation pursuant to Section 337.

The complaint alleges that the following entities (collectively, the “Proposed Respondents”) unlawfully import into the U.S., sell for importation, and/or sell within the U.S. after importation certain subsea telecommunication systems and components thereof that infringe one or more claims of U.S. Patent Nos. 8,380,068 (the ’068 patent), 7,860,403 (the ’403 patent), 8,971,171 (the ’171 patent), 8,351,798 (the ’798 patent), and 8,406,637 (the ’637 patent) (collectively, the “asserted patents”):
Share

Read More